Who owns your GP clinic? Why insurer-backed care is raising fresh questions
Australians generally expect their local GP clinic to be a straightforward part of the health system: you book an appointment, you see a doctor, and Medicare helps cover the cost. But a growing shift in the business of primary care is prompting a more basic question: who owns the clinic you visit, and what might that mean for the care you receive?
Major private health insurers, including Medibank Private and Bupa, have been open about buying and opening GP clinics. At the same time, all four major insurers are offering some free or heavily discounted telehealth-style GP consultations to members. These moves are being framed as innovations that improve access and support preventive care. However, doctors and health policy observers are warning that the trend could also accelerate a two-tier system, where privately insured patients find it easier and cheaper to see a GP than those relying solely on Medicare.
A warning sign from overseas, and why it resonates locally
In the United States, it is not uncommon to see GP clinics display signs indicating they will not accept certain categories of patients, such as those using Medicaid. That reality is often cited as a symptom of a system where coverage status can determine access, and where uninsured patients can face worse outcomes. The comparison is not perfect—Medicaid is a government-subsidised program for low-income earners in the US and is not the same as Australia’s Medicare—but it illustrates how financial incentives can shape who gets care, and on what terms.
In the US, doctors can opt out of Medicaid, and sometimes do, because reimbursement rates are low. In Australia, GPs have long argued that Medicare rebates have not kept pace with the costs of running a practice. Against that backdrop, some doctors say the idea of “No Medicare” providers—particularly in online telehealth—no longer feels theoretical.
Insurers are moving beyond insurance
Private health insurers in Australia have traditionally been payers: they collect premiums and help cover approved health costs. But the current trend is that insurers are increasingly becoming providers as well. Medibank, for example, is buying up private hospitals and offering “hospital in the home” services through its subsidiary Amplar Health. Alongside these expansions, insurers are also entering primary care through GP clinics and telehealth offerings.
For patients, this can look like a convenient package: a health insurer that not only pays for some services but also directly provides or coordinates them. For clinicians and regulators, it raises a different set of questions about incentives, conflicts of interest, and whether the structure of care is being reshaped in ways that could limit choice over time.
Telehealth discounts: legal, popular, and controversial
A key part of the debate involves insurer-funded telehealth consultations. These telehealth-style GP visits are not covered by Medicare, and insurers are paying for them in their entirety. The ability for insurers to fund these services is described as the result of a confluence of two laws that essentially make the arrangement legal.
Insurers argue that anyone can access these telehealth services, and that may be true in a technical sense. But critics say the more important issue is the price point. By making consultations cheaper for members, insurers can create a second tier of access: people with private cover may find it easier to get an appointment because it is more affordable for them, while others face higher out-of-pocket costs or longer waits elsewhere.
This matters in a system already under pressure. Australia has a shortage of GPs, and if insurer-led services offer better pay or more attractive working conditions, they may draw doctors away from other parts of the system. Australian Medical Association vice president Julian Rait has pointed to this risk: in a tight workforce market, new models can shift where clinicians choose to work, and who benefits from that shift.
The two-tier concern: access, affordability, and the GP shortage
The phrase “two-tier system” can sound abstract, but the concern being raised is practical. If privately insured patients can access discounted or free insurer-funded telehealth, and if insurer-owned clinics expand, those patients may be able to obtain GP consultations more quickly or at lower cost. Meanwhile, patients who rely on Medicare alone may face increasing barriers, especially if Medicare rebates continue to lag behind costs.
In that environment, the emergence of “No Medicare” doctors in the telehealth space becomes a plausible outcome, according to the concerns being voiced. The logic is not that doctors oppose Medicare, but that if the economics of delivering care under Medicare become increasingly difficult, some providers may choose models where Medicare is not part of the transaction at all.
Managed care: why doctors are uneasy
The expansion of insurers into GP clinics, telehealth, private hospitals, and home-based hospital care has prompted concern among doctors that Australia may be moving toward an insurer-directed system often referred to as “managed care.” The concept is associated with insurers having a stronger role in shaping what care is delivered, where it is delivered, and under what conditions.
One of the central worries is not simply ownership, but incentives. The Australian Medical Association has raised concerns that if a health insurer owns a GP clinic, it could create incentives for doctors to refer patients into the insurer’s own hospitals or a preferred network of specialists. There are rules designed to prevent such steering, but critics argue the conflict of interest can still be too great, and the potential for perverse incentives too high.
Even where patients have formal freedom to choose, the reality of healthcare decision-making can be more complicated. Patients can take a named referral to any provider, but many rely heavily on their GP to advise which specialist to see or which hospital best suits their condition. If the system nudges clinicians—subtly or overtly—toward certain pathways, the concern is that patient choice could narrow in practice, regardless of what is permitted on paper.
Choice and competition: why it matters
Supporters of insurer-led models may argue that they are trying to save patients money and improve access. Critics respond that there is a longer-term risk: if patients have less choice, prices can rise. The argument is that competition depends on meaningful options, and if vertical integration concentrates control—insurers owning or strongly influencing multiple parts of the care pathway—then the market may become less competitive over time.
This is not just a theoretical debate about structure. It touches everyday experiences: how quickly someone can see a GP, whether they can afford a consultation, which hospital they are directed to, and what treatments are considered available or appropriate.
Government stance and the question of what is already emerging
Health Minister Mark Butler has said the government does not support a two-tier system. Yet the concerns being raised by doctors and analysts are that the early signs of such a system are already appearing, driven by the economics of general practice, workforce shortages, and the growing role of insurers in delivering care.
Insurers, for their part, argue that Australia’s system is fundamentally different from the US. In several key ways, that is true. Australia has community rating, meaning anyone can buy health insurance regardless of health status, and private cover is not offered through employers in the same way it often is in the US. Insurers are also tightly regulated in what they can and cannot cover through the Basic-to-Gold policy system, and they must mostly mirror the Medicare committees that decide what is and is not covered.
Even so, critics argue insurers are “creeping” into more health spaces and pushing boundaries to influence care whenever laws allow. The concern is not that Australia will replicate the US system overnight, but that incremental changes—each legal, each presented as a service improvement—could cumulatively shift power and incentives in ways that are hard to reverse.
Specialists report growing insurer influence
The debate is not limited to GP clinics and telehealth. Orthopaedic surgeons, who do a large share of private hospital work, say they are seeing more insurer encroachment. Examples include policies not covering certain prostheses surgeons would like to use, and claims of rehabilitation limits in insurer contracts with hospitals—an issue the industry disputes.
These types of disputes point to a broader tension: where clinical judgment meets funding rules. When insurers become more active in shaping what is funded or how services are delivered, clinicians may feel their choices are constrained, and patients may experience those constraints as limits on available treatments or on where they can receive care.
Claims handling and delays: the “type C certificate” example
Concerns about insurer behaviour have also been highlighted through an ombudsman’s review of type C certificates. These certificates are used to allow a procedure normally performed in a specialist’s rooms to be done in a hospital and claimed on private health insurance.
One example described is a Parkinson’s patient who might need sedation to receive an eye injection. The ombudsman found some health insurers were questioning these certificates and leaving them in limbo, effectively rejecting claims through inertia. For patients and clinicians, delays like this can create uncertainty and stress, and can affect where and how care is delivered.
Preventive care pilots: promising, but not free of incentives
Not every insurer initiative is framed as cost-cutting. Some efforts are presented as well-intentioned attempts to improve preventive care. A pilot project in preventive health was launched in 2024 at three Myhealth medical centres. In western Sydney, a preventive care pilot run by Medibank Private is described as accessible to anyone.
There is no suggestion that anything is wrong with the pilot itself. Still, the incentives are clear: an insurer stands to benefit if preventive interventions reduce hospitalisations and therefore reduce insurance claims for its members. The theoretical issue raised by critics is what happens if insured patients receive preferential treatment, or if patients are directed toward certain interventions, providers, or timelines in ways that align with an insurer’s financial interests.
Preventive care and telehealth may be popular with many Australians, and they may deliver genuine benefits. The point being made by doctors raising concerns is that the bigger picture also matters: who controls access, who sets priorities, and how the system protects patient choice and equity when commercial incentives are embedded deeper into the delivery of care.
What patients can realistically watch for
For most patients, the immediate priority is simply getting an appointment and receiving good care. But as ownership and funding models evolve, the questions patients ask may need to broaden. Not because every insurer-backed service is problematic, but because transparency and safeguards become more important when the same organisation can play multiple roles in the care pathway.
Cost and coverage: whether a telehealth consultation is Medicare-funded or insurer-funded can affect both price and how the service operates.
Referral pathways: whether patients are being encouraged toward particular specialists or hospitals, and whether alternatives are discussed.
Choice and availability: whether certain services become easier to access for members than for non-members, particularly in a GP shortage.
Delays and administration: how claims processes and approvals can influence where procedures are performed and how quickly care proceeds.
A system at a crossroads
Australia’s healthcare system is not the United States, and the regulatory environment is different. Yet the pressures that drive “managed care” dynamics—workforce shortages, rising costs, and the search for efficiency—are increasingly present. At the same time, insurers are expanding into GP clinics, telehealth, hospitals, and home-based care, creating new models that blend funding and delivery.
The debate now is not simply about whether these services are convenient or innovative, but about what they mean for equity, patient choice, and clinical independence as the boundaries between insurer and provider blur. Australians may ultimately welcome more telehealth and preventive care. The challenge is ensuring that as these models grow, they do not quietly harden into a system where affordability and access depend more on insurance status than on medical need.